Experienced in Reactive Arthritis

Takako E. Nakajima

Kyoto, JP 
Experienced in Reactive Arthritis
Kyoto, JP 
OverviewLocationsClinical Research

Overview

Takako Nakajima practices in Kyoto, Japan. Ms. Nakajima is rated as an Experienced expert by MediFind in the treatment of Reactive Arthritis. Her top areas of expertise are Stomach Cancer, Colorectal Cancer, Periodontitis, Endoscopy, and Hepato-Pancreato-Biliary Surgery.

Her clinical research consists of co-authoring 108 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Reactive Arthritis.

Gender
Female

Locations

Kyoto, Japan
Other Locations
Nakajima, Japan
Kawahara, 6068507, Japan
Kawahara, 6068507, Japan
Funabashi, Japan
Okayama, 7168508, Japan
Osaka, Japan
St. Marianna University School of Medical Hospital
Kanagawa, 2168511, Japan
Chuo, 9518514, Japan
St. Marianna University School of Medicine
Kawasaki, Japan
St. Marianna University School of Medicine Hospital
Japan
Tokyo, Japan
Niigata, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase I, Open Label, Dose Escalation Study of The Safety and Pharmacokinetics of Anti-PD-L1 Monoclonal Antibody KN035 Administered in Subcutaneous Injection as A Single Agent to Japanese Subjects With Locally Advanced or Metastatic Solid Tumors
A Phase I, Open Label, Dose Escalation Study of The Safety and Pharmacokinetics of Anti-PD-L1 Monoclonal Antibody KN035 Administered in Subcutaneous Injection as A Single Agent to Japanese Subjects With Locally Advanced or Metastatic Solid Tumors
Enrollment Status: Completed
Publish Date: February 08, 2022
Intervention Type: Drug
Study Phase: Phase 1

108 Total Publications

Patients with periodontitis exhibit persistent dysbiosis of the gut microbiota and distinct serum metabolome.
Patients with periodontitis exhibit persistent dysbiosis of the gut microbiota and distinct serum metabolome.
Journal: Journal of oral microbiology
Published: May 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Nakajima's expertise for a condition
ConditionClose
View All 23 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile